HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SSYA10-001

a helicase inhibitor with antiviral activity; structure in first source

Also Known As:

3-((2-nitrophenyl)sulfanylmethyl)-4-prop-2-enyl-1H-1,2,4-triazole-5-thione

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Triazoles: 1533
      - SSYA10-001: 1

Experts

1.	Adedeji, Adeyemi O: 1 article (08/2014)
2.	Coleman, Christopher M: 1 article (08/2014)
3.	Elliott, Ruth: 1 article (08/2014)
4.	Frieman, Matthew B: 1 article (08/2014)
5.	Kassim, Ademola: 1 article (08/2014)
6.	Sarafianos, Stefan G: 1 article (08/2014)
7.	Singh, Kamalendra: 1 article (08/2014)
8.	Weiss, Susan R: 1 article (08/2014)

Related Diseases

1.	Severe Acute Respiratory Syndrome 08/01/2014 - "Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses."
2.	Coronavirus Infections 08/01/2014 - "Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses."
3.	Hepatitis 08/01/2014 - "Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses."